The Nasdaq has hit some turbulence this year. It's currently down more than 10% from its recent peak, which puts it in ...
Q4 2024 Earnings Call Transcript March 13, 2025 Cellectar Biosciences, Inc. beats earnings expectations. Reported EPS is ...